| Literature DB >> 27105115 |
Zhongyu Xie1, Di Zhang1, Dongjun Chung2, Zhanyun Tang3, He Huang1, Lunzhi Dai1, Shankang Qi1, Jingya Li4, Gozde Colak1, Yue Chen1, Chunmei Xia4, Chao Peng1, Haibin Ruan5, Matt Kirkey6, Danli Wang1, Lindy M Jensen7, Oh Kwang Kwon8, Sangkyu Lee8, Scott D Pletcher7, Minjia Tan4, David B Lombard9, Kevin P White6, Hongyu Zhao10, Jia Li4, Robert G Roeder3, Xiaoyong Yang11, Yingming Zhao12.
Abstract
Here we report the identification and verification of a β-hydroxybutyrate-derived protein modification, lysine β-hydroxybutyrylation (Kbhb), as a new type of histone mark. Histone Kbhb marks are dramatically induced in response to elevated β-hydroxybutyrate levels in cultured cells and in livers from mice subjected to prolonged fasting or streptozotocin-induced diabetic ketoacidosis. In total, we identified 44 histone Kbhb sites, a figure comparable to the known number of histone acetylation sites. By ChIP-seq and RNA-seq analysis, we demonstrate that histone Kbhb is a mark enriched in active gene promoters and that the increased H3K9bhb levels that occur during starvation are associated with genes upregulated in starvation-responsive metabolic pathways. Histone β-hydroxybutyrylation thus represents a new epigenetic regulatory mark that couples metabolism to gene expression, offering a new avenue to study chromatin regulation and diverse functions of β-hydroxybutyrate in the context of important human pathophysiological states, including diabetes, epilepsy, and neoplasia.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27105115 PMCID: PMC5540445 DOI: 10.1016/j.molcel.2016.03.036
Source DB: PubMed Journal: Mol Cell ISSN: 1097-2765 Impact factor: 17.970